These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

558 related items for PubMed ID: 12738332

  • 1. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
    Nag S, Quivey JM, Earle JD, Followill D, Fontanesi J, Finger PT, American Brachytherapy Society.
    Int J Radiat Oncol Biol Phys; 2003 Jun 01; 56(2):544-55. PubMed ID: 12738332
    [Abstract] [Full Text] [Related]

  • 2. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
    Vonk DT, Kim Y, Javid C, Gordon JD, Stea B.
    Brachytherapy; 2015 Jun 01; 14(5):726-33. PubMed ID: 26051804
    [Abstract] [Full Text] [Related]

  • 3. Palladium-103 plaque radiation therapy for American Joint Committee on cancer T3- and T4-staged choroidal melanomas.
    Semenova E, Finger PT.
    JAMA Ophthalmol; 2014 Feb 01; 132(2):205-13. PubMed ID: 24287555
    [Abstract] [Full Text] [Related]

  • 4. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
    Gündüz K, Shields CL, Shields JA, Cater J, Brady L.
    Am J Ophthalmol; 2000 Jul 01; 130(1):97-102. PubMed ID: 11004266
    [Abstract] [Full Text] [Related]

  • 5. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S.
    Ophthalmology; 2005 May 01; 112(5):834-40. PubMed ID: 15878063
    [Abstract] [Full Text] [Related]

  • 6. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
    Perez BA, Mettu P, Vajzovic L, Rivera D, Alkaissi A, Steffey BA, Cai J, Stinnett S, Dutton JJ, Buckley EG, Halperin E, Marks LB, Mruthyunjaya P, Kirsch DG.
    Int J Radiat Oncol Biol Phys; 2014 May 01; 89(1):127-36. PubMed ID: 24613808
    [Abstract] [Full Text] [Related]

  • 7. Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
    Filì M, Trocme E, Bergman L, See TRO, André H, Bartuma K, Girnita L, All-Eriksson C, Seregard S, Stålhammar G.
    Br J Ophthalmol; 2020 Jan 01; 104(1):26-32. PubMed ID: 30910871
    [Abstract] [Full Text] [Related]

  • 8. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
    Heindl LM, Lotter M, Strnad V, Sauer R, Naumann GO, Knorr HL.
    Ophthalmologe; 2007 Feb 01; 104(2):149-57. PubMed ID: 17123048
    [Abstract] [Full Text] [Related]

  • 9. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.
    American Brachytherapy Society - Ophthalmic Oncology Task Force. Electronic address: paulfinger@eyecancer.com, ABS – OOTF Committee.
    Brachytherapy; 2014 Feb 01; 13(1):1-14. PubMed ID: 24373763
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I, Heikkonen J, Summanen P, Tarkkanen A, Kivelä T.
    Ophthalmology; 2003 Nov 01; 110(11):2223-34. PubMed ID: 14597534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tumour control probability after Ruthenium-106 brachytherapy for choroidal melanomas.
    Espensen CA, Appelt AL, Fog LS, Thariat J, Gothelf AB, Aznar MC, Kiilgaard JF.
    Acta Oncol; 2020 Aug 01; 59(8):918-925. PubMed ID: 32412331
    [Abstract] [Full Text] [Related]

  • 14. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
    Finger PT, Chin KJ, Tena LB.
    Ophthalmology; 2012 Feb 01; 119(2):415-22. PubMed ID: 22133796
    [Abstract] [Full Text] [Related]

  • 15. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST, Astrahan MA, Finger PT, Followill DS, Meigooni AS, Melhus CS, Mourtada F, Napolitano ME, Nath R, Rivard MJ, Rogers DW, Thomson RM.
    Med Phys; 2012 Oct 01; 39(10):6161-84. PubMed ID: 23039655
    [Abstract] [Full Text] [Related]

  • 16. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
    Papageorgiou KI, Cohen VM, Bunce C, Kinsella M, Hungerford JL.
    Br J Ophthalmol; 2011 Feb 01; 95(2):166-70. PubMed ID: 20889528
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
    Le BHA, Kim JW, Deng H, Rayess N, Jennelle RL, Zhou SY, Astrahan MA, Berry JL.
    Brachytherapy; 2018 Feb 01; 17(6):981-989. PubMed ID: 30082188
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
    Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, Diddie KR, Engstrom RE, Finger PT, Hovland KR, Joffe L, Olsen KR, Wells CG, COMS Follow-up of Plaqued Eyes Working Group.
    Ophthalmology; 2020 Apr 01; 127(4S):S148-S157. PubMed ID: 32200815
    [Abstract] [Full Text] [Related]

  • 20. Clinical Predictors of Regression of Choroidal Melanomas after Brachytherapy: A Growth Curve Model.
    Rashid M, Heikkonen J, Singh AD, Kivelä TT.
    Ophthalmology; 2018 May 01; 125(5):747-754. PubMed ID: 29499831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.